Alzheimer's drug aducanumab not approved for use in EU
Charities are disappointed but regulators say there is still little evidence of the drug's benefit.
Image source, Getty Images
The European Medicines Agency has said no to approving a new drug for Alzheimer's disease in the EU.
Aducanumab does not appear to be effective at treating adults with ea… [+1878 chars]
Read More
Other Stories in BBC
- Australia waltz into World Cup final
- Reaction to international friendlies, Portugal & Senegal reach Qatar
- Has Bellingham made himself an England starter?
- Osaka through to Miami Open semis
- Shane Warne memorial - watch & follow updates
- Egypt fire: Dozens dead in Giza Coptic church
- Rushdie beginning road to recovery, agent says
- Moment explosion rocks shopping centre in Armenia
- US Taiwan: Congress team follows Pelosi with second high-level visit in a month